Boehringer to Work With Roche on Cancer Diagnostics

Boehringer Ingelheim (BI) has taken another step forward with its fledgling oncology business by signing a deal with a Roche subsidiary to develop cancer diagnostics. The German pharma company will work with Ventana Medical Systems to develop devices to help physicians determine which patients are suitable for treatment with BI’s personalised oncology products.
PMLiVE